The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia

By Ben-Hamadi R.   Duh M. S.   Aggarwal J.   Henckler A.   Mckenzie R. S.   Tak Piech C.  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1677-1682

Informa Healthcare

Access to resources Recommend Favorite

A randomized, controlled trial comparing darbepoetin alfa correction/maintenance dosing with weekly dosing for treating chemotherapy-induced anemia

By Kotasek Dusan   Canon Jean-Luc   Mateos Maria Victoria   Hedenus Michael   Rossi Greg   Taylor Kerry  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1387-1401

Informa Healthcare

Access to resources Recommend Favorite

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia**

By Hernandez Enrique   Ganly Peter   Charu Veena   DiBenedetto Joseph   Tomita Dianne   Lillie Tom   Taylor Kerry    

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2109-2120

Informa Healthcare

Access to resources Recommend Favorite

A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

By Mel J. R.   Salar A.   Rodríguez C. A.   Alegre A.   González A.   Cassinello J.   Montesinos J.   Gasquet J. A.   Sánchez J.   Saigí E.    

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2931-2942

Informa Healthcare

Access to resources Recommend Favorite

A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy‐associated anemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 361-8609, Iss. 10, 2015-10 ,pp. : 877-881

John Wiley & Sons Inc

Access to resources Recommend Favorite